Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Review

Zika virus: A primer for clinicians

Michelle S. Flores, MD, Timothy H. Burgess, MD, MPH and Michael Rajnik, MD
Cleveland Clinic Journal of Medicine April 2016, 83 (4) 261-270; DOI: https://doi.org/10.3949/ccjm.83a.16027
Michelle S. Flores
Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy H. Burgess
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Rajnik
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1

    Reported transmission of Zika virus in the Americas.

    From US Centers for Disease Control and Prevention. www.cdc.gov/zika/geo/americas.html

  • FIGURE 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2

    Tiered algorithm for arbovirus detection for suspected cases of chikungunya, dengue, or Zika virus infection. Testing is performed only if travel history indicates travel to affected area.

    a Due to extensive cross-reactivity in flavivirus serologic assays, molecular detection should be performed first for samples collected < 7 days post illness onset.

    b Perform if sample collected ≥ 4 days after symptom onset.

    c Extensive cross-reactivity would be expected in samples from dengue and Zika virus circulation areas. A positive IgM assay with either antigen should be confirmed by using PRNT against both Zika virus and dengue virus as well as any other flavivirus (eg, St. Louis encephalitis virus, Zika virus, West Nile virus) that might be found in that geographic area, including travel areas.

    d PRNT should include any flavivirus (eg, St. Louis encephalitis virus, Zika virus, West Nile virus) that might be found in that geographic area, including travel areas.

    Centers for Disease Control and Prevention. Updated diagnostic testing for Zika, chikungunya, and dengue viruses in US Public Health Laboratories. http://stacks.cdc.gov/view/cdc/37594

Tables

  • Figures
    • View popup
    TABLE 1

    Differential diagnosis of Zika virus infection

    Dengue
    Chikungunya
    Malaria
    Rickettsia
    Group A streptococci
    Rubella
    Measles
    Parvovirus
    Enterovirus
    Adenovirus
    Leptospirosis
    Alphavirus infections (in addition to chikungunya)
    • From Centers for Disease Control and Prevention. Zika virus clinical evaluation and disease. www.cdc.gov/zika/hc-providers/clinicalevaluation.html.

    • View popup
    TABLE 2

    Most common causes of congenital microcephaly

    GeneticAcquired
    IsolatedDisruptive injuries
    SyndromicInfections
    (TORCHES—toxoplasmosis,a rubella, cytomegalovirus,a herpes simplex virus, syphilis), human immunodeficiency virus
    Teratogens
    Deprivation (malnutrition, placental insufficiency, folate deficiency, maternal hypothyroidism)
    • ↵a Congenital toxoplasmosis is associated with diffuse intracranial calcifications; congenital cytomegalovirus is associated with periventricular calcifications.

    • Based on information in Ashwal S, Michelson D, Plawner L, Dobyns WB; Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2009; 73:887–897.

    • View popup
    TABLE 3

    Diagnostic tests for Zika virus

    PopulationTestWhen usedLimitations
    Healthy adults or childrenZika virus immunoglobulin M (IgM) in serum2–12 weeks of illnessPossible cross-reactivity with other flaviviruses
    Limited availability
    Real-time polymerase chain reaction (RT-PCR) in serumFirst week of illnessMay be negative by day 4 of illness
    Limited availability
    Plaque reduction neutralization assayConfirmatory testing for patients with positive IgMLimited availability
    Labor-intensive
    Pregnant womenFetal ultrasonographyPregnant women with a positive Zika virus test
    Pregnant women exposed to Zika virus who present after 12 weeks of exposure
    Needs to be repeated every 3–4 weeks during pregnancy
    Availability may be limited
    RT-PCR of amniotic fluidMicrocephaly or intracranial calcifications present on ultrasonographySignificance of results has not been conclusive
    Newborns suspected of being infectedHistopathology of umbilical cord and placentaFetal loss, Zika virus suspected
    Newborn with microcephaly and intracranial calcifications
    Presumptive diagnosis
    Limited availability
    RT-PCR of cord serum, frozen tissue (cord, placenta)Fetal loss, Zika virus suspected
    Newborn with microcephaly and intracranial calcifications
    Presumptive diagnosis
    Limited availability
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 83 (4)
Cleveland Clinic Journal of Medicine
Vol. 83, Issue 4
1 Apr 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Zika virus: A primer for clinicians
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Zika virus: A primer for clinicians
Michelle S. Flores, Timothy H. Burgess, Michael Rajnik
Cleveland Clinic Journal of Medicine Apr 2016, 83 (4) 261-270; DOI: 10.3949/ccjm.83a.16027

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Zika virus: A primer for clinicians
Michelle S. Flores, Timothy H. Burgess, Michael Rajnik
Cleveland Clinic Journal of Medicine Apr 2016, 83 (4) 261-270; DOI: 10.3949/ccjm.83a.16027
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • FLAVIVIRUSES: DENGUE, WEST NILE … ZIKA
    • OUT OF AFRICA AND ASIA
    • TRANSMITTED BY MOSQUITO
    • OTHER ROUTES OF TRANSMISSION
    • IS USUALLY ASYMPTOMATIC OR CAUSES MILD SYMPTOMS
    • CLINICAL ASSOCIATIONS
    • LABORATORY DIAGNOSTIC METHODS
    • IMPLICATIONS, RECOMMENDATIONS
    • TREATMENT
    • PREVENTION
    • WATCH FOR UPDATES
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • Zika—a new continent and new complications?
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Alpha-gal syndrome: Recognizing and managing a tick-bite–related meat allergy
  • Managing right ventricular failure in the setting of pulmonary embolism
  • Psychedelics, spirituality, and existential distress in patients at the end of life
Show more Review

Similar Articles

Subjects

  • Infectious Diseases
  • Neurology
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire